ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0038

Specific Binding of Uric Acid to NDFIP1 Associates with Hyperuricemia-induced Ferroptosis

Qiunan Zhu1, Hiroshi Arakawa2, Yoshiyuki Shirasaka2 and Ikumi Tamai2, 1Kanazawa University, Kanazawa, Japan, 2Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan

Meeting: ACR Convergence 2023

Keywords: hyperuricemia, Uric Acid, Urate

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0013–0039.5) Genetics, Genomics & Proteomics Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Hyperuricemia (HU) is reported as a risk factor for gout and associates with diverse diseases, including ulcerative colitis (UC), while its mechanism remains unclear. In this study, we aim to explain UA effect based on the hypothesis that UA-binding proteins function as UA sensors and regulate various physiological processes.

Methods: UA-binding proteins were detected by proteomics following a pull-down assay with UA-binding beads and human colorectal Caco-2 cells homogenate. Specific binding of these candidate binding proteins was confirmed by binding assay with in vitro synthesized proteins using cell-free method. UA was exposed to the cells after filtering by 0.2 μm filter to avoid UA crystals. The cellular levels of iron, ROS, and lipid peroxidation (MDA) were measured with FerroOrange, CellROX®, MDA assay kit, respectively.

Results: Six proteins were found to be potential to bind to UA by pull-down assay. Specific binding of UA to these proteins was confirmed by binding assay using in vitro synthesized proteins, where NDFIP1 showed the highest binding rate (Fig. 1). Binding domain was narrowed down by binding assay with UA-binding beads and in vitro synthesized partial NDFIP1 protein. To find the binding sites, docking simulation of AlphaFold2-predicted NDFIP1 and UA was carried out. As a result, intracellular C-terminal sequences of NDFIP1 was suggested as UA-binding region.

Exposing UA to Caco-2 cells caused cell death and the viability decreased with increasing UA concentration (Fig. 2A). In addition, as UA significantly increased intracellular iron, ROS and MDA level (Fig. 2B-D), suggesting that high UA level could induce ferroptosis, which is associated with UC.

Since NDFIP1 is known as a ubiquitin ligase adaptor and promotes ubiquitination of DMT1 (divalent metal transporter 1, an iron transporter), mRNA and protein expressions of DMT1 were measured as Fig. 3, where UA increased DMT1 protein significantly but not mRNA level.

Exposure of DMT1 blocker 2 reduced UA-induced ferroptosis. Furthermore, knockdown of NDFIP1 by transfecting siRNA lowered the difference of ferroptosis level between UA exposed and control groups.

Conclusion: NDFIP1 was found as UA binding protein and was suggested as a UA sensor that regulates HU-induced ferroptosis by modulating DMT1.

Supporting image 1

Figure 1. Specific binding of NDFIP1 to UA.
NDFIP1 bound to UA-binding beads was approximately 7 times as much as that of control.

Supporting image 2

Figure 2. Ferroptosis induced by UA.
Exposing UA to Caco_2 cells caused cell death (A) and led to higher intracellular iron (B), ROS (C), and MDA (D) levels.

Supporting image 3

Figure 3. Effect of UA on DMT1 expression.
Exposing UA to Caco_2 cells increased DMT1 protein expression significantly (B), but not the mRNA level (A).


Disclosures: Q. Zhu: None; H. Arakawa: None; Y. Shirasaka: None; I. Tamai: None.

To cite this abstract in AMA style:

Zhu Q, Arakawa H, Shirasaka Y, Tamai I. Specific Binding of Uric Acid to NDFIP1 Associates with Hyperuricemia-induced Ferroptosis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/specific-binding-of-uric-acid-to-ndfip1-associates-with-hyperuricemia-induced-ferroptosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/specific-binding-of-uric-acid-to-ndfip1-associates-with-hyperuricemia-induced-ferroptosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology